$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | Wessel Thomas | Chief Medical Offic ... | Option Exercise | A | 20.59 | 6,500 | 133,835 | 6,500 | |
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | Wessel Thomas | Chief Medical Offic ... | Grant | A | 0.00 | 2,600 | 0 | 27,600 | 25 K to 27.6 K (+10.40 %) |
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | A | 20.59 | 37,500 | 772,125 | 37,500 | |
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Grant | A | 0.00 | 15,000 | 0 | 38,664 | 23.7 K to 38.7 K (+63.39 %) |
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 20.59 | 25,000 | 514,750 | 25,000 | |
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 18,266 | 8.3 K to 18.3 K (+120.98 %) |
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 20.59 | 62,500 | 1,286,875 | 62,500 | |
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 25,000 | 0 | 178,384 | 153.4 K to 178.4 K (+16.30 %) |
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | A | 20.59 | 40,000 | 823,600 | 40,000 | |
| Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Grant | A | 0.00 | 16,000 | 0 | 45,315 | 29.3 K to 45.3 K (+54.58 %) |
| Feb 26 2009 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | M | 2.60 | 1,923 | 5,000 | 0 | |
| Feb 26 2009 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 23.63 | 50,000 | 1,181,455 | 420,846 | 470.8 K to 420.8 K (-10.62 %) |
| Feb 26 2009 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 23.76 | 1,923 | 45,682 | 1,630 | 3.6 K to 1.6 K (-54.12 %) |
| Feb 26 2009 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Buy | M | 2.60 | 1,923 | 5,000 | 3,553 | 1.6 K to 3.6 K (+117.98 %) |
| Dec 03 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.09 | 100 | 1,709 | 8,266 | 8.4 K to 8.3 K (-1.20 %) |
| Dec 03 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.99 | 4,034 | 64,504 | 8,366 | 12.4 K to 8.4 K (-32.53 %) |
| Dec 03 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.98 | 2,500 | 39,950 | 23,664 | 26.2 K to 23.7 K (-9.56 %) |
| Dec 03 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 15.89 | 4,000 | 63,560 | 153,384 | 157.4 K to 153.4 K (-2.54 %) |
| Nov 26 2008 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 16.74 | 25,000 | 418,500 | 25,000 | |
| Sep 15 2008 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 27.40 | 25,000 | 684,950 | 470,846 | 495.8 K to 470.8 K (-5.04 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.30 | 100 | 2,930 | 157,384 | 157.5 K to 157.4 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.35 | 263 | 7,719 | 157,484 | 157.7 K to 157.5 K (-0.17 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.36 | 100 | 2,936 | 157,747 | 157.8 K to 157.7 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.37 | 100 | 2,937 | 157,847 | 157.9 K to 157.8 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.39 | 100 | 2,939 | 157,947 | 158 K to 157.9 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.40 | 100 | 2,940 | 158,047 | 158.1 K to 158 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.42 | 100 | 2,942 | 158,147 | 158.2 K to 158.1 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.44 | 145 | 4,269 | 158,247 | 158.4 K to 158.2 K (-0.09 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.46 | 192 | 5,656 | 158,392 | 158.6 K to 158.4 K (-0.12 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.48 | 200 | 5,896 | 158,584 | 158.8 K to 158.6 K (-0.13 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.49 | 300 | 8,847 | 158,784 | 159.1 K to 158.8 K (-0.19 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.50 | 100 | 2,950 | 159,084 | 159.2 K to 159.1 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.51 | 200 | 5,902 | 159,184 | 159.4 K to 159.2 K (-0.13 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.52 | 199 | 5,874 | 159,384 | 159.6 K to 159.4 K (-0.12 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.53 | 100 | 2,953 | 159,583 | 159.7 K to 159.6 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.56 | 101 | 2,986 | 159,683 | 159.8 K to 159.7 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.57 | 100 | 2,957 | 159,784 | 159.9 K to 159.8 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.58 | 200 | 5,916 | 159,884 | 160.1 K to 159.9 K (-0.12 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.59 | 307 | 9,084 | 160,084 | 160.4 K to 160.1 K (-0.19 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.60 | 300 | 8,880 | 160,391 | 160.7 K to 160.4 K (-0.19 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.61 | 300 | 8,883 | 160,691 | 161 K to 160.7 K (-0.19 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.62 | 800 | 23,696 | 160,991 | 161.8 K to 161 K (-0.49 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.63 | 924 | 27,378 | 161,791 | 162.7 K to 161.8 K (-0.57 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.64 | 100 | 2,964 | 162,715 | 162.8 K to 162.7 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.64 | 1,046 | 31,003 | 162,815 | 163.9 K to 162.8 K (-0.64 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.65 | 1,100 | 32,615 | 163,861 | 165 K to 163.9 K (-0.67 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.66 | 1,554 | 46,092 | 164,961 | 166.5 K to 165 K (-0.93 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.67 | 1,100 | 32,637 | 166,515 | 167.6 K to 166.5 K (-0.66 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.68 | 800 | 23,744 | 167,615 | 168.4 K to 167.6 K (-0.48 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.69 | 949 | 28,176 | 168,415 | 169.4 K to 168.4 K (-0.56 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 25,000 | 65,000 | 464,317 | |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.70 | 1,000 | 29,700 | 169,364 | 170.4 K to 169.4 K (-0.59 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.71 | 801 | 23,798 | 170,364 | 171.2 K to 170.4 K (-0.47 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.72 | 1,099 | 32,662 | 171,165 | 172.3 K to 171.2 K (-0.64 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.73 | 800 | 23,784 | 172,264 | 173.1 K to 172.3 K (-0.46 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.74 | 1,700 | 50,558 | 173,064 | 174.8 K to 173.1 K (-0.97 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.75 | 769 | 22,878 | 174,764 | 175.5 K to 174.8 K (-0.44 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.76 | 1,100 | 32,736 | 175,533 | 176.6 K to 175.5 K (-0.62 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.77 | 367 | 10,926 | 176,633 | 177 K to 176.6 K (-0.21 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.78 | 433 | 12,895 | 177,000 | 177.4 K to 177 K (-0.24 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.79 | 900 | 26,811 | 177,433 | 178.3 K to 177.4 K (-0.50 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.80 | 451 | 13,440 | 178,333 | 178.8 K to 178.3 K (-0.25 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.81 | 700 | 20,867 | 178,784 | 179.5 K to 178.8 K (-0.39 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.82 | 300 | 8,946 | 179,484 | 179.8 K to 179.5 K (-0.17 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.83 | 200 | 5,966 | 179,784 | 180 K to 179.8 K (-0.11 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.85 | 200 | 5,970 | 179,984 | 180.2 K to 180 K (-0.11 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.86 | 200 | 5,972 | 180,184 | 180.4 K to 180.2 K (-0.11 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.87 | 300 | 8,961 | 180,384 | 180.7 K to 180.4 K (-0.17 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.88 | 100 | 2,988 | 180,684 | 180.8 K to 180.7 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.89 | 300 | 8,967 | 180,784 | 181.1 K to 180.8 K (-0.17 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 29.97 | 200 | 5,994 | 181,084 | 181.3 K to 181.1 K (-0.11 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.00 | 100 | 3,000 | 181,284 | 181.4 K to 181.3 K (-0.06 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.03 | 39 | 1,171 | 181,384 | 181.4 K to 181.4 K (-0.02 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.04 | 61 | 1,832 | 181,423 | 181.5 K to 181.4 K (-0.03 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.17 | 400 | 12,068 | 181,484 | 181.9 K to 181.5 K (-0.22 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.32 | 200 | 6,064 | 181,884 | 182.1 K to 181.9 K (-0.11 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.34 | 100 | 3,034 | 182,084 | 182.2 K to 182.1 K (-0.05 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.46 | 100 | 3,046 | 182,184 | 182.3 K to 182.2 K (-0.05 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.48 | 100 | 3,048 | 182,284 | 182.4 K to 182.3 K (-0.05 %) |
| Sep 10 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 25,000 | 65,000 | 182,384 | 157.4 K to 182.4 K (+15.88 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.03 | 100 | 3,103 | 157,384 | 157.5 K to 157.4 K (-0.06 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.09 | 200 | 6,218 | 157,484 | 157.7 K to 157.5 K (-0.13 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.10 | 400 | 12,440 | 157,684 | 158.1 K to 157.7 K (-0.25 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.11 | 400 | 12,444 | 158,084 | 158.5 K to 158.1 K (-0.25 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.12 | 400 | 12,448 | 158,484 | 158.9 K to 158.5 K (-0.25 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.13 | 700 | 21,791 | 158,884 | 159.6 K to 158.9 K (-0.44 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.14 | 1,400 | 43,596 | 159,584 | 161 K to 159.6 K (-0.87 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.15 | 1,000 | 31,150 | 160,984 | 162 K to 161 K (-0.62 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.16 | 1,263 | 39,355 | 161,984 | 163.2 K to 162 K (-0.77 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.17 | 1,400 | 43,638 | 163,247 | 164.6 K to 163.2 K (-0.85 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.18 | 237 | 7,390 | 164,647 | 164.9 K to 164.6 K (-0.14 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.19 | 1,300 | 40,547 | 164,884 | 166.2 K to 164.9 K (-0.78 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.20 | 800 | 24,960 | 166,184 | 167 K to 166.2 K (-0.48 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.21 | 600 | 18,726 | 166,984 | 167.6 K to 167 K (-0.36 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.22 | 1,500 | 46,830 | 167,584 | 169.1 K to 167.6 K (-0.89 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.23 | 1,400 | 43,722 | 169,084 | 170.5 K to 169.1 K (-0.82 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 25,000 | 65,000 | 489,317 | |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.24 | 453 | 14,152 | 170,484 | 170.9 K to 170.5 K (-0.27 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.25 | 200 | 6,250 | 170,937 | 171.1 K to 170.9 K (-0.12 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.26 | 447 | 13,973 | 171,137 | 171.6 K to 171.1 K (-0.26 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.27 | 200 | 6,254 | 171,584 | 171.8 K to 171.6 K (-0.12 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.28 | 100 | 3,128 | 171,784 | 171.9 K to 171.8 K (-0.06 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.29 | 400 | 12,516 | 171,884 | 172.3 K to 171.9 K (-0.23 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.30 | 100 | 3,130 | 172,284 | 172.4 K to 172.3 K (-0.06 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.31 | 700 | 21,917 | 172,384 | 173.1 K to 172.4 K (-0.40 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.32 | 616 | 19,293 | 173,084 | 173.7 K to 173.1 K (-0.35 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.33 | 300 | 9,399 | 173,700 | 174 K to 173.7 K (-0.17 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.34 | 370 | 11,596 | 174,000 | 174.4 K to 174 K (-0.21 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.35 | 600 | 18,810 | 174,370 | 175 K to 174.4 K (-0.34 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.36 | 800 | 25,088 | 174,970 | 175.8 K to 175 K (-0.46 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.37 | 1,600 | 50,192 | 175,770 | 177.4 K to 175.8 K (-0.90 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.38 | 600 | 18,828 | 177,370 | 178 K to 177.4 K (-0.34 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.39 | 1,230 | 38,610 | 177,970 | 179.2 K to 178 K (-0.69 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.40 | 800 | 25,120 | 179,200 | 180 K to 179.2 K (-0.44 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.41 | 300 | 9,423 | 180,000 | 180.3 K to 180 K (-0.17 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.42 | 200 | 6,284 | 180,300 | 180.5 K to 180.3 K (-0.11 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.43 | 300 | 9,429 | 180,500 | 180.8 K to 180.5 K (-0.17 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.47 | 700 | 22,029 | 180,800 | 181.5 K to 180.8 K (-0.39 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.49 | 300 | 9,447 | 181,500 | 181.8 K to 181.5 K (-0.17 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.50 | 100 | 3,150 | 181,800 | 181.9 K to 181.8 K (-0.05 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.51 | 100 | 3,151 | 181,900 | 182 K to 181.9 K (-0.05 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.52 | 100 | 3,152 | 182,000 | 182.1 K to 182 K (-0.05 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.53 | 100 | 3,153 | 182,100 | 182.2 K to 182.1 K (-0.05 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.58 | 100 | 3,158 | 182,200 | 182.3 K to 182.2 K (-0.05 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 31.73 | 84 | 2,665 | 182,300 | 182.4 K to 182.3 K (-0.05 %) |
| Jul 09 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 25,000 | 65,000 | 182,384 | 157.4 K to 182.4 K (+15.88 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.86 | 200 | 6,172 | 308,801 | 309 K to 308.8 K (-0.06 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.82 | 11,709 | 360,871 | 309,001 | 320.7 K to 309 K (-3.65 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.80 | 11,109 | 342,157 | 320,710 | 331.8 K to 320.7 K (-3.35 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.63 | 400 | 12,252 | 331,819 | 332.2 K to 331.8 K (-0.12 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.62 | 300 | 9,186 | 332,219 | 332.5 K to 332.2 K (-0.09 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.61 | 900 | 27,549 | 332,519 | 333.4 K to 332.5 K (-0.27 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.60 | 7,980 | 244,188 | 333,419 | 341.4 K to 333.4 K (-2.34 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.59 | 900 | 27,531 | 341,399 | 342.3 K to 341.4 K (-0.26 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.58 | 2,700 | 82,566 | 342,299 | 345 K to 342.3 K (-0.78 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.57 | 400 | 12,228 | 344,999 | 345.4 K to 345 K (-0.12 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.56 | 200 | 6,112 | 345,399 | 345.6 K to 345.4 K (-0.06 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.55 | 1,100 | 33,605 | 345,599 | 346.7 K to 345.6 K (-0.32 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.54 | 600 | 18,324 | 346,699 | 347.3 K to 346.7 K (-0.17 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.53 | 1,900 | 58,007 | 347,299 | 349.2 K to 347.3 K (-0.54 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.52 | 1,300 | 39,676 | 349,199 | 350.5 K to 349.2 K (-0.37 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.51 | 1,700 | 51,867 | 350,499 | 352.2 K to 350.5 K (-0.48 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.50 | 3,800 | 115,900 | 352,199 | 356 K to 352.2 K (-1.07 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.41 | 400 | 12,164 | 355,999 | 356.4 K to 356 K (-0.11 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.34 | 300 | 9,102 | 356,399 | 356.7 K to 356.4 K (-0.08 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.33 | 900 | 27,297 | 356,699 | 357.6 K to 356.7 K (-0.25 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.22 | 1,202 | 36,324 | 357,599 | 358.8 K to 357.6 K (-0.34 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Sell | S | 30.20 | 185,000 | 5,587,000 | 358,801 | 543.8 K to 358.8 K (-34.02 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.76 | 100 | 3,176 | 29,315 | 29.4 K to 29.3 K (-0.34 %) |
| Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 31.75 | 200 | 6,350 | 29,415 | 29.6 K to 29.4 K (-0.68 %) |